Phase-II, Gagret, Una
Learn about online consultations Your consultation is where your treatment journey begins
A synthetic analogue of alpha-melanocyte stimulating hormone
Receptor Selectivity and Baseline Desensitization: Evaluating the structural differences between Ipamorelin (highly selective for GH release) and GHRP-2 (which acts as a broader secretagogue) to observe downstream shifts in adrenocorticotropic hormone (ACTH), cortisol, and prolactin expression in vitro
Bessette and Anderson found that 89% ( 95% CI, 87.9-90.1), 88.9% (95% CI, 87.8-90) and 90.6% (95% CI, 89.5-91.6) of the cohort met the criteria for treatment with semaglutide, liraglutide (Saxenda, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly), respectively
GLP-1 agonists are generally safe and well-tolerated, but ongoing monitoring ensures any issues are identified and managed promptly, optimising both your diabetes control and cardiovascular health